INDICATIONS AND USAGE
Alsava is indicated for treatment of amyotrophic lateral sclerosis (ALS).
DOSAGE AND ADMINISTRATION
The recommended dosage is 60 mg administrated as an intravenous infusion over 60 minutes as follows:
Initial treatment cycle: daily dosing for 14 days followed by a 14 day drug-free period Subsequent treatment cycles: daily dosing for 10 days out of 14 day periods, followed by 14-day drug-free periods.
DOSAGE FORMS AND STRENGTHS
Injection: 30 mg/20 ml vial.
STORAGE OF TOFAXHA
Store Alsava at room temperature (up to 30°C).